Aster Capital Management’s Spruce Biosciences SPRB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$49 Buy
+1
New +$51 ﹤0.01% 948

Other funds holding SPRB

Aster Capital Management's SPRB Position: Q3 2026 in Review

Aster Capital Management opened a new position in Spruce Biosciences (SPRB) in Q3 2026: 1 share worth $49. The stake represents ﹤0.01% of the portfolio and ranks #948 among its holdings.

70 funds tracked by Wall St. Rank hold SPRB as of Q3 2026.

  • Aster Capital Management held 1 share of Spruce Biosciences worth $49 as of Q3 2026.
  • Spruce Biosciences was a new Aster Capital Management position in Q3 2026.
  • Spruce Biosciences made up ﹤0.01% of Aster Capital Management's portfolio in Q3 2026, its #948 holding.
  • 70 funds tracked by Wall St. Rank held Spruce Biosciences as of Q3 2026.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.